Value Hunters: Look To Zentalis Pharmaceuticals Inc (ZNTL)
Currently, there are 70.77M common shares owned by the public and among those 62.42M shares have been available to trade. Insiders at the company have transacted a total of 18 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 8 of these insider trades were purchases, […]
Zentalis Pharmaceuticals Inc (NASDAQ: ZNTL): The Best-Of-Breed For Investing?
Eventide Asset Management LLC recently announced the acquisition of new stake in Zentalis Pharmaceuticals Inc (NASDAQ:ZNTL). The institutional investor has increased its shareholding in the Healthcare company by 47.94% to 11.56 million shares with purchase of 3.75 million shares. This fresh investment now brings its stake to 16.34% valued currently at $130.05 million. In addition, […]
